European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Past deals in Wearables

.Lumen

Venture Round in 2025
Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

Photon IP

Grant in 2025
Photon IP is a deeptech startup located in Eindhoven, the Netherlands, specializing in the development of advanced technologies for photonics applications. The company focuses on creating application-specific semiconductors that cater to various industries, including automotive and telecommunications. Its innovative products are designed to enhance the production of wearable electronics and improve data center operations, providing tailored solutions that address the evolving needs of its clients.

.Lumen

Venture Round in 2024
Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

Neuro Event Labs

Convertible Note in 2023
Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Mistikist

Seed Round in 2023
Mistikist is an AI-driven mental wellbeing platform designed to alleviate stress and enhance focus through personalized audio-visual brainwave entrainment. By leveraging advanced neuroscience and machine learning, along with real-time biometrics such as heart rate variability, Mistikist customizes each experience to meet individual user needs, providing measurable improvements in just minutes. The platform caters to both business and consumer markets, offering subscription-based solutions for individuals and enterprise licensing for organizations. Accessible via mobile applications, virtual reality headsets, and wearables, Mistikist integrates seamlessly into users' lifestyles, promoting cognitive performance and resilience for professionals, students, and wellness enthusiasts globally.

Afon Technology

Grant in 2022
Afon Technology specializes in the development of non-invasive blood glucose monitoring devices aimed at benefiting individuals with diabetes. The company’s innovative technology allows for real-time, pain-free tracking of blood glucose levels, offering features such as continuous detection, potential pre-diabetic identification, and alarm alerts for high and low glucose levels. Users can access trend profiles and time-in-range statistics through a user-friendly app compatible with both iOS and Android systems. Additionally, Afon Technology’s device can transform any smartwatch into a glucose monitoring tool, providing fast and accurate measurements, data logging, and personalized health trends. This approach enhances daily management for diabetics, ultimately reducing the risk of diabetes-related complications.

Restore Medical

Grant in 2022
Restore Medical is a medical device company based in Or Yehuda, Israel, established in 2016. The company specializes in providing innovative treatment solutions for patients suffering from congestive heart failure. Its flagship product, ContraBand, is a catheter-delivered implant designed specifically for patients with left ventricle failure who have preserved right ventricle function. This device aims to enhance left ventricle ejection fraction, minimize mitral regurgitation, and restore optimal ventricular geometry. By addressing these critical issues, Restore Medical's technology seeks to significantly improve patient quality of life and decrease rates of hospital readmission.

Lindhe Xtend

Venture Round in 2022
Lindhe Xtend is a company specializing in the development and sale of user-friendly, flexible prostheses and accessories. Committed to enhancing the quality of life for amputees, Lindhe Xtend designs its products with the goal of enabling users to lead active and independent lives. The company's prosthetics are crafted from composite materials, allowing for adaptability to uneven terrain and various daily situations. By collaborating closely with users during the design process, Lindhe Xtend ensures that its solutions are tailored to meet the real needs of individuals, ultimately promoting freedom of movement and a more natural lifestyle.

Lindhe Xtend

Grant in 2022
Lindhe Xtend is a company specializing in the development and sale of user-friendly, flexible prostheses and accessories. Committed to enhancing the quality of life for amputees, Lindhe Xtend designs its products with the goal of enabling users to lead active and independent lives. The company's prosthetics are crafted from composite materials, allowing for adaptability to uneven terrain and various daily situations. By collaborating closely with users during the design process, Lindhe Xtend ensures that its solutions are tailored to meet the real needs of individuals, ultimately promoting freedom of movement and a more natural lifestyle.

Xsensio

Seed Round in 2021
Xsensio is a digital health company focused on addressing the critical challenge of real-time and continuous monitoring of health parameters. The company has developed an innovative Lab-on-Skin wearable device, which serves as a modular miniaturized sensing platform. This device enables the continuous and real-time analysis of biochemical information, including proteins and hormones, at the surface of the skin. By providing unprecedented access to a wide range of biochemical parameters found in sweat, such as electrolytes and metabolites, Xsensio aims to enhance patient care in a simple and minimally invasive manner. Through this technology, the company seeks to transform healthcare from a static approach to a more dynamic and responsive model.

Intelligent Implants

Seed Round in 2021
Intelligent Implants is a bioelectronics company based in Cork, Ireland, founded in 2014 by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer. The company specializes in wireless implantable electronics designed to stimulate, steer, and monitor bone growth. Its innovative electrotherapeutic devices provide solutions to treat diseases and facilitate the recovery of bone and other tissues. By integrating data, engineering, and medical expertise, Intelligent Implants develops active and connected medical devices that enhance patient treatment and support healthcare professionals in decision-making. The company's technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to utilize electro-therapeutics to manage patient conditions effectively.

.Lumen

Grant in 2021
Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

.Lumen

Venture Round in 2021
Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

PKvitality

Series A in 2021
PKvitality is a bio-wearable company based in Paris, France, that specializes in innovative health monitoring solutions. Founded in 2017, the company has developed K’Track, a line of trackers that assess key physiological markers through skin analysis, eliminating the need for blood samples. Its flagship product, K’Watch Glucose, is a continuous glucose monitoring device designed in the form of a smartwatch, featuring a micro-needle sensor that allows diabetics to monitor their glucose levels painlessly and discreetly. The device provides real-time alerts through on-body vibrations for hypo or hyperglycemic episodes, enhancing user convenience and safety. In addition to glucose monitoring, PKvitality is expanding its offerings to include continuous lactate monitoring and multi-analyte monitors, further advancing the field of wearable health technology.

NanoVation

Venture Round in 2021
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.

Contego Sports

Grant in 2021
Contego Sports Limited is a company based in Galway, Ireland, that specializes in the manufacture and sale of innovative head guards for rugby players. Founded in 2014 by Mark and Dr. Sandra Ganly, the company combines expertise in sports equipment design and biomedical engineering to develop advanced protective gear. Their flagship product, the N-Pro head guard, is designed to reduce the incidence and severity of brain injuries by effectively managing head impact energy. Contego Sports distributes its products online, aiming to enhance player safety in contact sports through cutting-edge technology and research-driven design.

GlucoModicum

Venture Round in 2021
GlucoModicum is a company dedicated to developing innovative, needle-free health and biomarker monitoring technologies. It specializes in creating a glucose monitoring solution that utilizes precise magnetohydrodynamic technology. The company's primary product is a wrist-worn device equipped with a replaceable sensor that allows users to continuously monitor glucose levels in their blood. This device is designed for diabetic patients, enabling them to track their health effectively and manage their blood glucose levels independently. The data collected by the device can be synchronized with smartphones and uploaded to the cloud, providing users with valuable insights into their health.

Intelligent Implants

Grant in 2021
Intelligent Implants is a bioelectronics company based in Cork, Ireland, founded in 2014 by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer. The company specializes in wireless implantable electronics designed to stimulate, steer, and monitor bone growth. Its innovative electrotherapeutic devices provide solutions to treat diseases and facilitate the recovery of bone and other tissues. By integrating data, engineering, and medical expertise, Intelligent Implants develops active and connected medical devices that enhance patient treatment and support healthcare professionals in decision-making. The company's technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to utilize electro-therapeutics to manage patient conditions effectively.

GlucoModicum

Grant in 2021
GlucoModicum is a company dedicated to developing innovative, needle-free health and biomarker monitoring technologies. It specializes in creating a glucose monitoring solution that utilizes precise magnetohydrodynamic technology. The company's primary product is a wrist-worn device equipped with a replaceable sensor that allows users to continuously monitor glucose levels in their blood. This device is designed for diabetic patients, enabling them to track their health effectively and manage their blood glucose levels independently. The data collected by the device can be synchronized with smartphones and uploaded to the cloud, providing users with valuable insights into their health.

TRIBUTE BRAND

Grant in 2020
TRIBUTE BRAND is a high-end digital fashion brand and a pioneer in the fashion technology sector, recognized for its distinct contactless and cyber aesthetics. The company operates a virtual marketplace for non-fungible token (NFT) clothing, providing digital fashion garments that promote sustainable design practices. By facilitating the purchase of digital clothing, TRIBUTE BRAND aims to reduce the environmental impact associated with traditional fashion, addressing issues such as waste, sizing limitations, and gender stereotypes. This innovative approach not only enhances consumer choice but also encourages more sustainable behaviors within the fashion industry.

Mode Sensors

Venture Round in 2020
Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.

Mode Sensors

Grant in 2020
Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.

Neuro Event Labs

Series A in 2020
Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Neuro Event Labs

Grant in 2020
Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Xsensio

Venture Round in 2020
Xsensio is a digital health company focused on addressing the critical challenge of real-time and continuous monitoring of health parameters. The company has developed an innovative Lab-on-Skin wearable device, which serves as a modular miniaturized sensing platform. This device enables the continuous and real-time analysis of biochemical information, including proteins and hormones, at the surface of the skin. By providing unprecedented access to a wide range of biochemical parameters found in sweat, such as electrolytes and metabolites, Xsensio aims to enhance patient care in a simple and minimally invasive manner. Through this technology, the company seeks to transform healthcare from a static approach to a more dynamic and responsive model.

Xsensio

Grant in 2020
Xsensio is a digital health company focused on addressing the critical challenge of real-time and continuous monitoring of health parameters. The company has developed an innovative Lab-on-Skin wearable device, which serves as a modular miniaturized sensing platform. This device enables the continuous and real-time analysis of biochemical information, including proteins and hormones, at the surface of the skin. By providing unprecedented access to a wide range of biochemical parameters found in sweat, such as electrolytes and metabolites, Xsensio aims to enhance patient care in a simple and minimally invasive manner. Through this technology, the company seeks to transform healthcare from a static approach to a more dynamic and responsive model.

PKvitality

Grant in 2020
PKvitality is a bio-wearable company based in Paris, France, that specializes in innovative health monitoring solutions. Founded in 2017, the company has developed K’Track, a line of trackers that assess key physiological markers through skin analysis, eliminating the need for blood samples. Its flagship product, K’Watch Glucose, is a continuous glucose monitoring device designed in the form of a smartwatch, featuring a micro-needle sensor that allows diabetics to monitor their glucose levels painlessly and discreetly. The device provides real-time alerts through on-body vibrations for hypo or hyperglycemic episodes, enhancing user convenience and safety. In addition to glucose monitoring, PKvitality is expanding its offerings to include continuous lactate monitoring and multi-analyte monitors, further advancing the field of wearable health technology.

NanoVation

Grant in 2019
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.

NanoVation

Venture Round in 2019
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.